Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson's and Huntington's disease
- PMID: 36408105
- PMCID: PMC9667083
- DOI: 10.3389/fnagi.2022.1031908
Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson's and Huntington's disease
Abstract
Background: The semiology and determinants of apathy are largely unknown across amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Huntington's disease (HD), due to both motor and non-motor confounders. This study thus aimed at (1) profiling apathy in ALS, PD, and HD and (2) exploring its clinical determinants.
Materials: Consecutive ALS (N = 99), PD (N = 73), and HD (N = 25) patients underwent a motor-free assessment of apathy (Dimensional Apathy Scale, DAS), global cognition, anxiety and depression. Function was assessed through disease-specific scales. The DAS was also completed by N = 101 healthy controls (HCs). Between-group comparisons on DAS scores were implemented by covarying for all applicable confounders. Predictive models on DAS scores were built through multiple, stepwise regressions.
Results: Parkinson's disease and HD, but not ALS, patients were more apathetic than HCs-with HD patients also selectively showing lower initiation and poorer goal-directed planning than HCs. Higher apathetic features were detected in PD and HD as compared to ALS. Education was a protective factor against apathy in ALS. Anxiety was a risk factor for global apathy in ALS, HD, and to a lesser extent, in PD, whereas, protective only toward affective disintegration in PD and ALS. Cognitive inefficiency was a risk factor toward apathy in both PD and ALS. Depression was a risk factor for executive-related apathy in PD.
Discussion: This study provides unprecedented insights into the heterogeneous semiology and determinants of apathy across ALS, PD, and HD via the DAS, in turn informing clinical practice and research.
Keywords: Huntington’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; apathy; neuropsychology.
Copyright © 2022 Poletti, Solca, Maffi, Torre, Carelli, Aiello, Ferrucci, Priori, Monti, Verde, Ticozzi, Migliore, Scaricamazza, Casella, Squitieri, Ciammola and Silani.
Conflict of interest statement
Author VS received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., and Novartis Pharma AG, received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call, and was in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology. Authors BP and LC received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. Author NT received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. Author FSq received compensation for consulting services and/or speaking activities from La Hoffman-Roche, Novartis, PTC Therapeutics, Wave Life Science, Prilenia. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.Mov Disord Clin Pract. 2021 Feb 12;8(3):361-370. doi: 10.1002/mdc3.13147. eCollection 2021 Apr. Mov Disord Clin Pract. 2021. PMID: 33816664 Free PMC article.
-
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson's disease: a validation study of the dimensional apathy scale.Qual Life Res. 2017 Sep;26(9):2533-2540. doi: 10.1007/s11136-017-1569-6. Epub 2017 Apr 7. Qual Life Res. 2017. PMID: 28389975
-
Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.Eur Neurol. 2018;79(1-2):13-20. doi: 10.1159/000481981. Epub 2017 Nov 13. Eur Neurol. 2018. PMID: 29131091
-
Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson's disease.Amyotroph Lateral Scler Frontotemporal Degener. 2023 Jun 22:1-10. doi: 10.1080/21678421.2023.2220748. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 37349906 Review.
-
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1546-1556. doi: 10.1007/s00259-018-4033-0. Epub 2018 May 1. Eur J Nucl Med Mol Imaging. 2018. PMID: 29717332 Review.
Cited by
-
Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients.Neurol Sci. 2024 Mar;45(3):1087-1095. doi: 10.1007/s10072-023-07074-3. Epub 2023 Sep 29. Neurol Sci. 2024. PMID: 37773576 Free PMC article.
-
Association between apathy and caregiver burden in patients with amyotrophic lateral sclerosis: a cross-sectional study.BMJ Open. 2024 Sep 3;14(9):e080803. doi: 10.1136/bmjopen-2023-080803. BMJ Open. 2024. PMID: 39231554 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous